Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration

Objective:  To address whether switch of depression into hypomania or mania or cycle acceleration in patients with bipolar disorder is caused by antidepressants or whether this phenomenon is attributable to the natural history of bipolar disorder itself.

[1]  David J Miklowitz,et al.  Effectiveness of adjunctive antidepressant treatment for bipolar depression. , 2007, The New England journal of medicine.

[2]  T. Suppes,et al.  Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline , 2006, British Journal of Psychiatry.

[3]  M. Bauer,et al.  Do antidepressants influence mood patterns? A naturalistic study in bipolar disorder , 2006, European Psychiatry.

[4]  T. Suppes,et al.  Lower switch rate in depressed patients with bipolar II than bipolar I disorder treated adjunctively with second-generation antidepressants. , 2006, The American journal of psychiatry.

[5]  H. Grunze,et al.  Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? , 2006, European Archives of Psychiatry and Clinical Neuroscience.

[6]  M. Tohen,et al.  Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression. , 2005, The Journal of clinical psychiatry.

[7]  H. Visser,et al.  Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review , 2005, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[8]  G. Goodwin,et al.  Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. , 2004, The American journal of psychiatry.

[9]  Michael Bauer,et al.  Using technology to improve longitudinal studies: self-reporting with ChronoRecord in bipolar disorder. , 2004, Bipolar disorders.

[10]  J. Amsterdam,et al.  Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate. , 2004, Bipolar disorders.

[11]  R. Post,et al.  Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. , 2003, The Journal of clinical psychiatry.

[12]  Heping Zhang,et al.  Recurrence of bipolar disorders and major depression , 2003, European archives of psychiatry and clinical neuroscience.

[13]  L. Judd,et al.  The long-term course of rapid-cycling bipolar disorder. , 2003, Archives of general psychiatry.

[14]  C. Bradshaw,et al.  The effect of acute tryptophan depletion on probabilistic choice , 2003, Journal of psychopharmacology.

[15]  A. Gamma,et al.  A new bipolar spectrum concept: a brief review. , 2002, Bipolar disorders.

[16]  Eduard Vieta,et al.  A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. , 2002, The Journal of clinical psychiatry.

[17]  F K Goodwin,et al.  Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. , 2000, The Journal of clinical psychiatry.

[18]  L. Altshuler,et al.  Antidepressant-induced mania and cycle acceleration: a controversy revisited. , 1995, The American journal of psychiatry.

[19]  M. Peet.  Induction of Mania with Selective Serotonin Re-uptake Inhibitors and Tricyclic Antidepressants , 1994, British Journal of Psychiatry.

[20]  D. Ciraulo,et al.  Fluoxetine treatment of bipolar II depression. , 1991, Journal of clinical psychopharmacology.

[21]  J. Cohn,et al.  A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. , 1989, International clinical psychopharmacology.

[22]  R. Post,et al.  Graphic representation of the life course of illness in patients with affective disorder. , 1988, The American journal of psychiatry.

[23]  F. Goodwin,et al.  Can antidepressants cause mania and worsen the course of affective illness? , 1987, The American journal of psychiatry.

[24]  D J Kupfer,et al.  Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. , 1984, Archives of general psychiatry.

[25]  T. Rosenthal,et al.  Bipolar outcome in the course of depressive illness. Phenomenologic, familial, and pharmacologic predictors. , 1983, Journal of affective disorders.

[26]  F. Quitkin,et al.  Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. , 1981, Archives of general psychiatry.

[27]  R. Fieve,et al.  Clinical factors in lithium carbonate prophylaxis failure. , 1974, Archives of general psychiatry.

[28]  R. Prien,et al.  Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness. , 1973, Archives of general psychiatry.

[29]  A. B. Hill.  The Environment and Disease: Association or Causation? , 1965, Proceedings of the Royal Society of Medicine.

[30]  R. Kahn,et al.  Behavioral patterns in convulsive therapy. , 1961, Archives of general psychiatry.

[31]  G. Deshaies.  [Antisocial reactions in the Mayenne region]. , 1954, Annales medico-psychologiques.

[32]  D. Ploog.  „Psychische Gregenregulation“ dargestellt am Verlaufe von Elektroschockbehandlungen , 1950, Archiv für Psychiatrie und Nervenkrankheiten.

[33]  J. Baillarger.  Sobre la locura de doble forma (De la folie a double forme) , 2004 .

[34]  P. Andersen,et al.  Recurrence of bipolar disorders and major depression: a life-long perspective , 2004 .

[35]  C. Henry,et al.  Avoiding Drug-Induced Switching in Patients with Bipolar Depression , 2003, Drug safety.

[36]  A. Young,et al.  The British Association for Psychopharmacology guidelines for treatment of bipolar disorder: a summary. , 2003, Journal of psychopharmacology.

[37]  M. Thase,et al.  Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision) , 2003 .

[38]  J. Kane,et al.  Extending indications for long-term pharmacotherapy: opportunities and challenges. , 2002, The American journal of psychiatry.

[39]  H. Grunze,et al.  Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? , 2000, European Archives of Psychiatry and Clinical Neuroscience.

[40]  P. Pichot.  The birth of the bipolar disorder , 1995, European Psychiatry.

[41]  W. Coryell,et al.  Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. , 1992, Archives of general psychiatry.

[42]  Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. Danish University Antidepressant Group. , 1990, Journal of affective disorders.

[43]  J. Angst.  Switch from depression to mania--a record study over decades between 1920 and 1982. , 1985, Psychopathology.